ETFs Holding OPHT »    OPHT Historical Stock Prices »
OPHT News Video: Mon, Nov 28, 2016, 1:03 PM — Monday's ETF Movers: GDXJ, XBI

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Ophthotech is a biopharmaceutical company focusing on the development of therapeutics to treat ophthalmic diseases, with a focus on age-related and orphan retinal diseases. Co. is developing Zimura® (avacincaptad pegol), its complement C5 inhibitor, for dry and wet forms of age-related macular degeneration, which is a disorder of the central portion of the retina, known as the macula, that may result in loss of central vision, and autosomal recessive Stargardt disease, which is an orphan inherited retinal disease that also may result in loss of central and peripheral vision. Self directed investors in IVERIC bio Inc will be interested in keeping up with all IVERIC bio Inc news they can find, both OPHT news originating from the company in the form of press releases, as well as seeing how independent media outlets are reporting news on OPHT. At RediNews, we simplify this task by presenting both OPHT news releases originating from IVERIC bio Inc itself, and OPHT news from a variety of media outlets. Visitors can browse this news online and through our OPHT RSS news feed.


OPHT News — Articles, Videos, & Press Releases

Ophthotech Gets Rights to Gene Therapy for BEST Disease
Friday, April 12, 2019, 8:02 AM — Zacks
Top Ranked Momentum Stocks to Buy for March 7th
Thursday, March 7, 2019, 7:18 AM — Zacks
Ophthotech's (OPHT) Q4 Loss Wider, Gene Therapy in Focus
Wednesday, February 27, 2019, 9:35 AM — Zacks
OPHT is categorized under the Healthcare sector; below are links to news for some other companies in the same sector:

VTL News
APT News

Anyone with a stock market portfolio cares about more than stock market price information, or the historical stock price of the stocks they own, or whether their stocks show up on the latest top ten stocks list. They also care about news. What news is coming out of the company, and, what are third party articles and videos saying? Your web site content may feature an excellent stock market screener and nice web page chart graphics, but if you are lacking in the news offerings you are missing a big reason for visitors to return to your site. People form habits, one of which is to check the weather forecast, another is to check the stock market price levels of the major indices, and a third is to check the news for their stocks they own. So don't pass up integrating our free RediNews RSS news feeds. Simply navigate to any RediNews news page by specific ticker symbol or by sector, then click the RSS icon for that news page to reach the associated RSS feed (the icon will look like this): .

OPHT News | | Copyright © 2013 - 2019, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.